Encephalopathy - hypertensive
Methodology & AI Transparency ⓘ
Encephalopathy - hypertensive Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Clinical coding for Encephalopathy - hypertensive uses ICD-10 I67.4 across Heart & Vascular specialty care.
- 3 Typical cash cost range: Workup highlights for Encephalopathy - hypertensive (I67.4): coronary perfusion imaging [Encephalopathy - hypertensive I67.4].
- 4 Top reported side effects / signs: Longitudinal Encephalopathy - hypertensive monitoring tracks Left Ventricular Ejection in Encephalopathy - hypertensive (I67.4: Fraction (LVEF)) toward 55% – 70% (I67.4).
Ask our AI Specialists anything about Encephalopathy - hypertensive
What Is Encephalopathy - hypertensive?
Recognized across U.S. clinical coding as I67.4 (Heart & Vascular), Encephalopathy - hypertensive is evaluated via coronary perfusion imaging [Encephalopathy - hypertensive I67.4] to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Encephalopathy - hypertensive (I67.4) center on structural ventricular wall in Encephalopathy - hypertensive (I67.4: stress). targeted heart & vascular interventions aim to normalize Left Ventricular Ejection in Encephalopathy - hypertensive (I67.4: Fraction (LVEF)).
Common Symptoms & Clinical Signs
- • Presentation of Encephalopathy - hypertensive (I67.4): palpitations, skipped beats, in Encephalopathy - hypertensive (I67.4: or irregular resting)
- • Secondary Encephalopathy - hypertensive clinical sign: unexplained lower-extremity ankle in Encephalopathy - hypertensive (I67.4: edema or rapid)
- • Symptom flares in Encephalopathy - hypertensive correlating with Left Ventricular Ejection in Encephalopathy - hypertensive (I67.4: Fraction (LVEF)) deviation outside 55% – 70% (I67.4)
- • Functional heart & vascular impact requiring coronary perfusion imaging [Encephalopathy - hypertensive I67.4] evaluation (I67.4)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Encephalopathy - hypertensive Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I67.4 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Left Ventricular Ejection in Encephalopathy - hypertensive (I67.4: Fraction (LVEF)) | 55% – 70% (I67.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [Encephalopathy - hypertensive I67.4] | < 100 pg/mL (I67.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: High-Sensitivity Troponin I [Encephalopathy - hypertensive I67.4] | < 14 ng/L (I67.4) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Encephalopathy - hypertensive
Treatment selection for Encephalopathy - hypertensive depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Encephalopathy - hypertensive)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate: What a 414-Participant Study Found Adjuvant erythropoietin did not reduce the incidence of regional brain injury. Developmental neuroscience • 2024-01-15 • Phase III Randomized Trial | N = 414 | 93/100 | PMID 37906983 ↗ |
| Can This Approach Help? Inside the Latest Research on Early onset radiation-induced leukoencephalopathy in patients treated for a This study reports a high incidence (29%) of early-onset RIL in glioblastoma patients treated with the Stupp protocol, highlighting the question of individual sensitivity to this severe side effect. Revue neurologique • 2026-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41644378 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of L-carnitine on quality of life in covert liver encephalopathy: a Twenty-four weeks of L-carnitine supplementation was safe but ineffective in improving quality of life and liver function. The Korean journal of internal medicine • 2022-07-15 • Phase III Randomized Trial | N = 150 | 88/100 | PMID 35526858 ↗ |
| Can This Approach Help? Inside the Latest Research on Losartan in heart failure. blood pressure and heart rate effects and This study showed that oral losartan administered to patients with symptomatic heart failure resulted in beneficial blood flow and heart rate effects with short-term administration, with additional beneficial blood flow and... Circulation • 1995-02-01 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 7828295 ↗ |
| Can This Approach Help? Inside the Latest Research on A multicentre, randomized study of telmisartan versus carvedilol for prevention Telmisartan was significantly more effective than carvedilol in preventing recurrent AF episodes in hypertensive AF patients, despite a similar lowering of blood pressure. Journal of the renin-angiotensin-aldosterone system : JRAAS • 2012-12-15 • Randomized Controlled Trial | N = 70 | 82/100 | PMID 22546623 ↗ |
Encephalopathy - hypertensive Patient Community & “People Like Me” Threads
Filter Encephalopathy - hypertensive community threads and patient logs by age, biological sex, dosage, and treatment duration.